| 3.94 -0.13 (-3.19%) | 01-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.93  |
1-year : | 5.37 |
| Resists | First : | 4.22 |
Second : | 4.59 |
| Pivot price | 3.95 |
|||
| Supports | First : | 3.6 |
Second : | 3 |
| MAs | MA(5) : | 3.98 |
MA(20) : | 3.95 |
| MA(100) : | 3.11 |
MA(250) : | 2.6 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 69.3 |
D(3) : | 70.9 |
| RSI | RSI(14): 52.3 |
|||
| 52-week | High : | 4.59 | Low : | 1.97 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ KRMD ] has closed above bottom band by 42.9%. Bollinger Bands are 61.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 4.2 - 4.23 | 4.23 - 4.24 |
| Low: | 3.74 - 3.77 | 3.77 - 3.8 |
| Close: | 3.89 - 3.94 | 3.94 - 3.98 |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Tue, 14 Jan 2025
KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $5.00 - MarketBeat
Mon, 13 Jan 2025
KORU Medical Reports Record Q4: Revenue Surges 23% to $8.9M with Positive Cash Flow - StockTitan
Mon, 25 Nov 2024
KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference - Business Wire
Sat, 16 Nov 2024
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10 - Simply Wall St
Thu, 14 Nov 2024
KORU Medical Systems Inc (KRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Delays - GuruFocus.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 33 (M) |
| Held by Insiders | 6.3 (%) |
| Held by Institutions | 54.3 (%) |
| Shares Short | 487 (K) |
| Shares Short P.Month | 457 (K) |
| EPS | -0.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | -38.2 % |
| Operating Margin | -14.2 % |
| Return on Assets (ttm) | -14.2 % |
| Return on Equity (ttm) | -50.3 % |
| Qtrly Rev. Growth | 21.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.67 |
| EBITDA (p.s.) | -0.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -15.16 |
| PEG Ratio | 0 |
| Price to Book value | 8.75 |
| Price to Sales | 5.86 |
| Price to Cash Flow | -436.87 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|